DISCLOSURES
Ryan W. Harrison, Robert R. McLean, and Blessing Dube are employees of Corrona, LLC. Abby S. Van Voorhees has received grant/research support from Celgene, Lilly, AbbVie; Consultant: Celgene, Dermtech, and WebMD.
Funding sources: This study was sponsored by Corrona, LLC and the analysis was funded by Corrona LLC. Access to study data was limited to Corrona and Corrona statisticians completed all of the analysis; all authors contributed to the interpretation of the results. Corrona Psoriasis Registry is sponsored by Corrona, LLC and is funded by AbbVie, Boehringer Ingelheim, Eli Lilly and Company, Janssen, Novartis Pharmaceuticals Corporation, and Valeant.
The authors thank the participating providers and patients for contributing data to the Corrona® Psoriasis Registry. This study was supported through a partnership between the Corrona® Psoriasis Registry and the National Psoriasis Foundation Medical Board.
References
1. Menter A, Strober BE, Kaplan DH, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol. Apr 2019;80(4):1029-1072. doi:10.1016/j.jaad.2018.11.057
2. Galli E, Liu G, Leslie D, Kirby J, Miller JJ. Prescription pattern variability of biologic therapies in treating psoriasis. J Psoriasis Psoriatic Arthritis. 2018/07/01 2018;3(3):84-87. doi:10.1177/2475530318781308
3. Nguyen KB, Read C, Wu KK, Armstrong AW. Where you live matters: Regional differences in healthcare resource use for psoriasis in the United States. J Am Acad Dermatol. Oct 10 2019;doi:10.1016/j.jaad.2019.10.014
4. Takeshita J, Gelfand JM, Li P, et al. Psoriasis in the US Medicare population: prevalence, treatment, and factors associated with biologic use. J Invest Dermatol. Dec 2015;135(12):2955-2963. doi:10.1038/jid.2015.296
5. Enos, CW, et al., Predictors of Biologic Use and Satisfaction Among Patients With Psoriasis: An Analysis and Geographic Visualization of the 2016 and 2017 National Psoriasis Foundation Annual Surveys. J Psoriasis Psoriatic Arthritis. 2020. 5(3):100-108.
6. Langan SM, Seminara NM, Shin DB, et al. Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J Invest Dermatol. Mar 2012;132(3 Pt 1):556-62. doi:10.1038/jid.2011.365
7. Barker LE, Kirtland KA, Gregg EW, Geiss LS, Thompson TJ. Geographic distribution of diagnosed diabetes in the U.S.: a diabetes belt. Am J Prev Med. Apr 2011;40(4):434-9. doi:10.1016/j.amepre.2010.12.019
8. Gurka MJ, Filipp SL, DeBoer MD. Geographical variation in the prevalence of obesity, metabolic syndrome, and diabetes among US adults. Nutr Diabetes. Mar 13 2018;8(1):14. doi:10.1038/s41387-018-0024-2
AUTHOR CORRESPONDENCE
Abby S. Van Voorhees MD vanvooas@evms.edu
